Related references
Note: Only part of the references are listed.How to study anxiety and depression in rodent models of chronic pain?
Melanie Kremer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
New agents and perspectives in the pharmacological treatment of major depressive disorder
Marsal Sanches et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Individual Differences in Response to Antidepressants A Meta-analysis of Placebo-Controlled Randomized Clinical Trials
Marta M. Maslej et al.
JAMA PSYCHIATRY (2021)
The Delta-Opioid Receptor; a Target for the Treatment of Pain
Beatrice Quirion et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Targeting opioid dysregulation in depression for the development of novel therapeutics
Caroline A. Browne et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Treatment Selection in Depression
Zachary D. Cohen et al.
Annual Review of Clinical Psychology (2018)
Depression and pain: primary data and meta-analysis among 237952 people across 47 low- and middle-income countries
B. Stubbs et al.
PSYCHOLOGICAL MEDICINE (2017)
Effect of treatments for depression on quality of life: a meta-analysis
Stefan G. Hofmann et al.
COGNITIVE BEHAVIOUR THERAPY (2017)
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S. Malhi et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2015)
Pain and depression comorbidity: A preclinical perspective
Jun-Xu Li
BEHAVIOURAL BRAIN RESEARCH (2015)
Delta opioid agonists: a concise update on potential therapeutic applications
J. F. Peppin et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)
Recent advances on the δ opioid receptor: from trafficking to function
Louis Gendron et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The Epidemiology of Depression Across Cultures
Ronald C. Kessler et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Delta opioid receptors in brain function and diseases
Paul Chu Sin Chung et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder An Updated Meta-analysis
Gerald Gartlehner et al.
ANNALS OF INTERNAL MEDICINE (2011)
A Review of Current Guidelines for Depression Treatment
Alan J. Gelenberg
JOURNAL OF CLINICAL PSYCHIATRY (2010)
EFFECTS OF NEUROKININ-1 RECEPTOR AGONISM AND ANTAGONISM IN THE ROSTRAL VENTROMEDIAL MEDULLA OF RATS WITH ACUTE OR PERSISTENT INFLAMMATORY NOCICEPTION
M. V. Hamity et al.
NEUROSCIENCE (2010)
JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide], a Selective Delta Opioid Receptor Agonist, Is a Potent and Efficacious Antihyperalgesic Agent That Does Not Produce Respiratory Depression, Pharmacologic Tolerance, or Physical Dependence
Ellen E. Codd et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Problems associated with long-term treatment with selective serotonin reuptake inhibitors
C. Moret et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia
Malika Benbouzid et al.
BIOLOGICAL PSYCHIATRY (2008)
Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception
Raf Jan-Filip Schepers et al.
PAIN (2008)
Central κ-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine:: Behavioral and BDNF mRNA expression studies
Huina Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects
EM Jutkiewicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through δ- and μ-opioid receptors independent of antidepressant-like effects
HN Zhang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Opening the DOR on antidepressant effects
Emily M. Jutkiewicz
MOLECULAR INTERVENTIONS (2006)
Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats
EM Jutkiewicz et al.
PSYCHOPHARMACOLOGY (2005)
Pharmacologic treatment of depression in patients with heart disease
SP Roose et al.
PSYCHOSOMATIC MEDICINE (2005)
Depression and pain comorbidity - A literature review
MJ Bair et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8a alpha,8a beta,12b beta)]7,10-dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[ 2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses
P Petrillo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats
DC Broom et al.
PSYCHOPHARMACOLOGY (2002)
Behavioral effects of δ-opioid receptor agonists:: Potential antidepressants?
DC Broom et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Nonpeptidic δ-opioid receptor agonists reduce immobility in the forced swim assay in rats
DC Broom et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Antinociception by tricyclic antidepressants in the rat formalin test: differential effects on different behaviours following systemic and spinal administration
J Sawynok et al.
PAIN (2001)
Mice deficient for δ- and γ-opioid receptors exhibit opposing alterations of emotional responses
D Filliol et al.
NATURE GENETICS (2000)
Antihyperalgesic effects of δ opioid agonists in a rat model of chronic inflammation
GL Fraser et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
